Suhardi, K. F. (2025) “Empagliflozin for liver and lipid profile in metabolic dysfunction-associated fatty liver disease: a meta-analysis”, Medical Journal of Indonesia, 34(4), pp. 268–77. doi: 10.13181/mji.oa.257855.